首页> Transplantation direct> Ravulizumab in Preemptive Living Donor Kidney Transplantation in Hereditary Atypical Hemolytic Uremic Syndrome.

Ravulizumab in Preemptive Living Donor Kidney Transplantation in Hereditary Atypical Hemolytic Uremic Syndrome.

导出 LinkOut

翻译打印收藏纠错

第一作者： Tilman,Schmidt

第一单位： Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

作者： Tilman,Schmidt ^[1] ; Markus,Gödel ^[1] ; Maida,Mahmud ^[2] ; Lutz,Fischer ^[3] ; Tobias B,Huber ^[2] ; Malte A,Kluger ^[2] ; Florian,Grahammer ^[2]

作者单位： Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. ^[1] Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.;University Transplant Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. ^[2] University Transplant Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.;Department of Visceral Transplant Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. ^[3]

DOI 10.1097/TXD.0000000000001289

PMID 35187213

发布时间 2022-02-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Transplantation direct

2022年8卷2期

e1289页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Transplantation direct

2022年8卷2期

e1289页

检索历史清除

Ravulizumab in Preemptive Living Donor Kidney Transplantation in Hereditary Atypical Hemolytic Uremic Syndrome.

Transplantation direct

相似文献

同项目论文

Transplantation direct

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Ravulizumab in Preemptive Living Donor Kidney Transplantation in Hereditary Atypical Hemolytic Uremic Syndrome.

Transplantation direct

相似文献

同项目论文

Transplantation direct

相关期刊

检索历史清除